Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the 2nd Quarter and Half year ended 30 September, 2026.

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 29 October 2026 Corporate Relationship Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Ref.: Scrip Code: BSE: 530549 & NSE: SHILPAMED Dear Sir, Sub: Board Meeting intimation under Regulation 29 of SEBI (LODR) Regulations, 2015. Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of Shilpa Medicare Limited is scheduled to be held on Thursday, 5 November 2026 inter alia to consider and approve unaudited financial results of the Company (Consolidated and Standalone) for the second quarter & half year ended 30th September 2026. In terms of the Code of Conduct for Prevention of Insider Trading in Securities of the Company, we wish to inform you that the Trading Window was closed on 01 October 2026 and will remain closed till 7 November 2026 (both the days inclusive). Weblink: https://www.vbshilpa.com/stock-exchange-intimations.php This is for your information and records. Yours faithfully, For Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer